Diversity in Homeostatic Calcium Set Points Predicts Retinal Ganglion Cell Survival Following Optic Nerve Injury in vivo

Sean McCracken,Michael J. Fitzpatrick,Allison L. Hall,Zelun Wang,Daniel Kerschensteiner,Josh L. Morgan,Philip Raymond Williams
DOI: https://doi.org/10.2139/ssrn.4257426
2022-01-01
SSRN Electronic Journal
Abstract:Retinal ganglion cell (RGC) degeneration drives vision loss in common blinding diseases like glaucoma. In most degenerative conditions, both traumatic and disease-related, RGC death is triggered by axon injury in the optic nerve, often near the nerve head. Here, we study the contributions of Ca2+ dynamics and homeostatic Ca2+ levels to RGC death from axon injury in vivo by transpupillary 2-photon imaging of the ratiometric Ca2+ sensor Twitch2b. Contrary to observations in the damaged optic nerve and peripheral nerves, we find that Ca2+ elevations after optic nerve injury fail to propagate over distance in axons and do not reach RGC somas. Additionally, acute and chronic Ca2+ dynamics after optic nerve crush do not affect RGC survival. Instead, we discover that baseline Ca2+ levels vary widely between RGCs and predict their survival after axon injury. Using cell-type-specific targeting strategies, we find that well-surviving RGC types have higher baseline Ca2+ levels than poorly surviving RGC types. Finally, we observe considerable variation in the baseline Ca2+ levels of different RGCs of the same type, which are predictive of within-type differences in survival. Together, our results reveal a previously unknown diversity in RGC homeostatic Ca2+ set points. These homeostatic Ca2+ set points vary widely between and within RGC types and determine their survival after injury.Funding Information: S.M and Z.W. were supported by an Institutional National Research Service Award T32 EY013360. This work was supported by grants from Research to Prevent Blindness (Career Development Award, P.R.W and J.L.M.), BrightFocus Foundation (National Glaucoma Research P.R.W.), Alcon Research Institute (Young Investigator Award P.R.W.), and NIH Grants (EY032908 P.R.W.; EY027411, EY034001, and EY026978 D.K.; and EYE030623 and EY029313 to J.L.M). This work was supported by the Hope Center Viral Vectors Core at Washington University School of Medicine, an unrestricted grant (to the Department of Ophthalmology and Visual Sciences) from Research to Prevent Blindness, and Vision Core Grant P30 EY002687.Conflict of Interests: None to declare. Ethical Approval: All experimental procedures were performed in accordance with animal protocols approved by the International Animal Care and Use Committee at Washington University in St. Louis Medical School and in compliance with the NIH Guide for the Care and Use of Laboratory Animals.
What problem does this paper attempt to address?